Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 10 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Cash flows from operating activities:          
Net loss $ (1,837) $ (11,316) $ (10,247) $ (33,525)  
Reconciliation of net loss to net cash used in operating activities          
Depreciation     1,835 2,987  
Amortization of intellectual property     135 137  
Accretion of asset retirement obligation     36 34  
Fair value of common stock issued for consulting services     24 4,075  
Stock-based compensation     2,032 2,899  
Warrant expense     0 4,046  
Amortization of deferred financing costs     27 47  
Non-cash convertible note interest expense     0 2,556  
Non-cash interest expense     0 95  
Loss on disposal of Ebonex asset     0 90  
Loss on disposal of equipment     76 79  
Changes in operating assets and liabilities          
Accounts receivable     244 (988)  
Inventory     123 (1,058)  
Prepaid expenses and other current assets     492 (507)  
Accounts payable     (1,853) 2,763  
Accrued expenses     (1,543) (1,914)  
Deferred rent     0 (35)  
Other assets and liabilities     (373) (372)  
Net cash used in operating activities     (8,992) (18,591)  
Cash flows from investing activities:          
Purchases of property and equipment     (2,999) (8,146)  
Proceeds from sale of equipment     150 0  
Equipment deposits and other assets     (28) (1,122)  
Insurance proceeds     9,838 0 $ 21,800
Net cash provided by (used in) investing activities     6,961 (9,268)  
Cash flows from financing activities:          
Proceeds from issuance of common stock, net of transaction costs     0 29,380  
Proceeds from PPP Loan     332 0  
Payments on notes payable     (241) (221)  
Payments on convertible note     0 (6,651)  
Net cash provided by financing activities     91 22,508  
Net decrease in cash and cash equivalents     (1,940) (5,351)  
Cash and cash equivalents at beginning of period     7,575 20,892  
Cash and cash equivalents at end of period $ 5,635 $ 15,541 5,635 15,541 $ 5,635
Supplemental disclosure of cash flows information          
Cash paid for income taxes     2 2  
Cash paid for interest     448 454  
Supplemental disclosure of non-cash transactions          
Change in accounts receivable resulting from insurance funds held in escrow     7,600 0  
Change in property and equipment resulting from change in accounts payable     (1,263) (437)  
Change in property and equipment resulting from change in accrued expenses     (409) (259)  
Change in equity resulting from change in accrued expenses     $ 24 $ 1,300